Recombinant TK-vaccinia viruses containing the pBR322 sequence inserted in either orientation within the coding sequence of the viral thymidine kinase gene were constructed. They were characterized by genomic analysis, hybridization studies, reversion to wild-type virus by in vivo recombination, and rescue from their genomes of plasmids which contained all or parts of the pBR322 sequence. TK-cells were infected with one of these recombinant viruses and then transfected with pools of chimeric plasmids composed of a cloned herpes simplex virus thymidine kinase gene which contained upstream inserts of different vaccinia DNA fragments prepared by restriction or sonication. Recombination between homologous pBR322 sequences within infected cells generated selectable recombinant viruses in which expression of the herpes simplex virus thymidine kinase gene was promoted by the upstream vaccinia insert. These viruses were characterized by genomic analysis, hybridization, and in vivo or in vitro phosphorylation of 5-[125I]deoxycytidine as a specific assay for the expressed herpes simplex virus thymidine kinase. Vaccinia DNA inserts were isolated conveniently for transfer to bacteria by rescuing appropriate plasmids from the genome of recombinant viruses. The sequence of 100 nucleotides adjacent to the upstream region of the herpes simplex virus gene was determined in nine different inserts measuring 0.17 to 1.07 kilobase pairs.
Vaccinia virus is a large DNA virus with a 187-kilobase pair (kb) double-stranded genome (4, 18, 36) . Viral genes are expressed in a temporal fashion coordinated by regulatory mechanisms which are poorly understood. No evidence for the involvement of a splicing mechanism during viral gene expression has been obtained. Findings such as the replication of virus in cytoplasm, the packaging within virus particles of enzymes involved in the synthesis and processing of mRNA, and the coding by the virus of probably all of these enzymes are compatible with recent evidence suggesting that the virus has evolved unique transcriptional regulatory sequences distinct from procaryotic and eucaryotic consensus sequences (summarized in reference 35) .
In recent work aimed at using vaccinia virus as a cloning and expression vector, the herpes simplex virus thymidine kinase (HSV-TK) gene inserted into the vaccinia genome was expressed when sequences present immediately upstream of a mapped early vaccinia gene were translocated upstream of the HSV-TK gene (13) . This observation, extended later to upstream regions of the viral TK gene (14, 26) and more recently to those of a late gene (35) , served as the rationale for our experimental strategy for isolation of several viral genomic fragments which promoted HSV-TK expression when inserted upstream of this gene. We thought the analysis of sequences present on the recovered fragments might help to identify the functional sequences within cis-acting regulatory regions which may be present upstream of all vaccinia genes.
We inserted randomly cleaved fragments of the vaccinia genome upstream of a cloned HSV-TK gene and then constructed recombinant viruses which expressed this gene as determined by a specific assay. Since we had previously inactivated the vaccinia TK gene by recombining the entire pBR322 sequence into its coding region, by using methotrexate-containing medium, we were able to select the recombinant viruses expressing the chimeric HSV-TK gene. Flanking of these chimeric genes by the pBR322 sequence also enabled us to recover their upstream vaccinia DNA inserts by plasmid rescue. The sequence of 100 nucleotides adjacent to the 5' end of the HSV-TK gene revealed that different DNA fragments were isolated.
MATERIALS AND METHODS
Preparation of DNA. Extraction of DNA from purified virions has been described before (29) . For genetic analysis of potential recombinant viruses, the virus was isolated from the cytoplasm of infected monolayers by a described procedure (7) but without using mercaptoethanol, and DNA was then extracted by the same procedure as described for purified virus. Large-scale plasmid preparation and purification followed standard procedures (15) . Recombinant plasmids were screened by preparing minilysates as previously described (9) , except that a phenol-chloroform (1:1) extraction step was added before precipitation with ethanol or isopropanol.
Construction of plasmids. Plasmids were constructed for insertion of plasmid pBR322 within the body of the vaccinia TK gene as follows. The plasmid containing the HindIlI J genomic fragment inserted in pBR322 (2) was digested with HindIII, and the fragment was eluted from agarose gel after electrophoresis (6) . It was circularized with T4 DNA ligase and then linearized with EcoRI and subsequently ligated to pBR322 which had been cleaved with EcoRI and treated with calf intestinal phosphatase. The ligation mix was used 164 VASSEF ET AL. to transform Escherichia coli HB101 recipient, and minilysates of recombinant plasmids were screened by restriction analysis. Thus, two plasmids containing the inverted Hindlll J fragment in opposite orientations at the EcoRI site of pBR322 were obtained and designated pAV2 and pAV3.
Transfection methods. Infected mouse 1D (TK-) cells were transfected with plasmid DNA, using a procedure described previously (28) . A protoplast fusion technique (22, 24, 25) , expected to produce recombinant viruses more efficiently, was also used to transfect 1D cell monolayers which had been infected at a multiplicity of 0.1 PFU 1.5 h earlier. Protoplasts were prepared from plasmid-harboring E. coli HB101 bacteria after chloramphenicol amplification as previously described (22) . Usually, methotrexate-containing medium (28) which also contained 30 jig of kanamycin per ml was added immediately after transfection. The following day the monolayer was washed twice with medium and incubated for another day in the above medium. Then fresh 1D cells were added in the same medium and the plates were incubated for 2 more days. Infectious centers were counted under a microscope before the plates were frozen and thawed three times for virus yield measurements. Plaque isolation of TK+ viruses was carried out first in methotrexatecontaining medium, using 96-well plates (0.1 PFU per well). This procedure did not eliminate completely the residual TK-viruses (see below), and therefore additional plaque isolation cycles were carried out in regular medium.
Plasmid rescue. The genomic DNA of recombinant vaccinia viruses containing a continuous or interrupted pBR322 sequence was digested with one of several restriction enzymes which would maintain the plasmid origin of replication along with one or both antibiotic resistance genes in one fragment. After phenol-chloroform (1:1) extraction, the fragments were circularized with T4 DNA ligase at low DNA concentrations (1 to 2 p.g/ml). E. coli HB101 recipient was transformed with the ligation mix and transformants were selected with the appropriate antibiotic.
Hybridization procedures. Agarose gel was dried and prepared (21) treated vaccinia DNA inserts, respectively, were mixed for growing as three plasmid pools (Fig. 2) . These are referred to as the Sau3A, BclI, and sonication (plasmid) pools, respectively.
Analysis of DNA from the three plasmid pools after digestion with PvuII or Sacl plus SalI (Fig. 3) showed that the bands corresponding to pAGO without any inserts (Fig.  3 , triangles on the left of lane 1 and the right of lane 6) were almost absent in the Sau3A pool (Fig. 3, lanes 3 and 6) but present in small amounts in the BclI and sonication pools (Fig. 3, lanes 1, 2, 4, and 5) . A similar analysis of plasmid pools after Sau3A digestion and comparison with Sau3A-digested pAGO (Fig. 3, lanes 7 to 10) showed that all three pools contained essentially equimolar amounts of the 1.1-and 0.6-kb bands which flanked the vaccinia DNA inserts. These results indicate that the two Sau3A sites bordering the inserts were conserved (Fig. 3, lanes 8 and 9) or regenerated after repair (Fig. 3, lane 7) . The presence of numerous submolar bands after digestion of the plasmid pools indicates that they contained a large variety of vaccinia DNA inserts (Fig. 3, lanes 1 to 9) , as expected.
Transfections producing mixtures of recombinant viruses expressing HSV-TK. Protoplasts from plasmid pool cultures or from pAGO culture were used to transfect 1D cells which had been infected with the VpB3 recombinant (Fig. 2 ), using the procedure described above. In this experiment, we expected to obtain site-specific insertion of the HSV-TK sequence present in plasmids at the PsvuII site of the pBR322 sequence in VpB3 due to the pBR322 sequence homology flanking this site in both VpB3 and individual plasmids (Fig.   2 ). DNA from plasmids or plasmid pools was digested with the restriction enzymes shown at the top and separated by electrophoresis on 1.2% agarose gels. The gels were stained with ethidium bromide and photographed under UV light. Molecular weight markers for lanes 1 to 6 were lambda HindIII fragments with the sizes shown on the left. For other lanes, molecular weight markers were Sau3A fragments of pBR322 separated in lane 11 with the sizes indicated on the right. The triangles on the left of lane 1 and the right of lane 6 show the expected positions of the bands corresponding to pAGO without vaccinia DNA inserts. thus lead to elimination of pBR322, the TK+ virus products of transfection experiments were likely to contain wt virus as well. Moreover, the sequence of the vaccinia TK gene (10, 34) shows the absence of a Sau3A site in the body of the gene and the presence of such sites 87 bp upstream and 270 bp downstream. Thus, our Sau3A, BcIl, and even sonication plasmid pools would presumably contain this fragment as an insert. Although the plasmid containing this insert should, based on the above observations, lead to elimination of pBR322 in VpB3, it could also insert the fragment into VpB3 via pBR322 homology. The resulting recombinant virus would also express the vaccinia TK gene in spite of the presence of the HSV-TK gene. We therefore proceeded to distinguish those TK+ plaques which expressed the HSV-TK gene under the control of vaccinia DNA fragments from a relatively small fraction of plaques that expressed the vaccinia TK gene. This was done by using iododeoxycytidine (IdC), which is recognized as a substrate by HSV-TK enzyme (27) but not by vaccinia TK enzyme (13, 20) .
Several TK+ plaques were obtained from transfection products after a single cycle of plaque isolation in methotrexate-containing medium and were subsequently propagated in the same medium. The resulting virus stocks were used to characterize the expressed TK by two methods. Cell extracts, prepared 1 or 2 days after infecting 1D cell monolayers, were incubated with 125IdC, and the formation of [1251I]deoxycytidylate was examined directly by chromatography of the reaction products as described above. IdC was converted also to iododeoxyuridine by extracts from uninfected 1D cells (data not shown) presumably by the cellular deoxycytidine deaminase activity since this conversion was inhibited by tetrahydrouridine (see reference 27 for a discussion and other references). To render the celi-free assay more sensitive for detecting low levels of HSV-TK activity, it was necessary to inhibit the competing conversion of IdC to iododeoxyuridine by adding tetrahydrouridine in incubations. Expression of HSV-TK was also detected by autoradiography of viral plaques after labeling with '25IdC. This method has been previously used to characterize recombinant vaccinia viruses expressing the HSV-TK gene either after upstream insertion of the sequenced cis-acting regions of a mapped vaccinia gene (13) or under the control of a putative promoter present near the BamHI site of the HindIll F genomic fragment (20 Fig. 4 ; other data not shown). When examined by autoradiography of viral plaques, the same 24 isolates gave positive results (the top three rows analyzed in Fig. 5 were among these). Although not shown, the results with the two negative plaque isolates were essentially identical to those observed with wild-type virus. Plaque isolate 22 analyzed in Fig. 5 was later shown to contain two recombinant viruses, one of which, VpT22a, will be mentioned below. Of the 18 tested TK+ plaque isolates originating from the sonication pool, only 10 were found to express HSV-TK (VpT35 in Fig. 5 is one example) and the others presumably expressed vaccinia TK (see isolate 34 in Fig. 4 and 5 ). Of the three tested plaque isolates derived from the BclI pool, two were positive for HSV-TK expression and VpT38 (Fig. 5) Fig. 6 . The upper weakly hybridizing band of VpT63 probably corresponds to undigested viral DNA. Other results showed that the BamHI site was also absent in the insert of viruses analyzed in Fig.  6 , although recombinant viruses containing inserts of 1 to 2 kb with sites for either or both endonucleases were obtained (data not shown). The data shown in Fig. 6 prove the purity of the new plaque isolates, and comparison with the results after one cycle of plaque isolation (data not shown) establishes that exogenous DNA is integrated into the genome of these recombinant viruses in a stable manner.
Recovery of vaccinia DNA inserts from the genome of VpT recombinant viruses by plasmid rescue. An advantage of our method is that vaccinia DNA inserts promoting expression of the HSV-TK gene can be readily recovered for further studies from the genome of VpT recombinant viruses by plasmid rescue. The procedure was as described earlier for VpB2 and VpB3 except that PvuII or enzymes that cleave the HSV sequence or the vaccinia inserts were not used for rescue in order to recover the inserts in intact form.
We used BamHI or HindIll digestion and ampicillin selection to rescue plasmids (designated pT plasmids; Fig. 2 ) from genomic DNA of 10 VpT recombinant viruses after two or more cycles of plaque isolation. However, it should be noted that this rescue does not require the isolation of completely pure viruses because the transfer of vaccinia inserts to E. coli leads to their isolation in pure form.
The 10 pT plasmids were grown and purified. The sequence of the HSV-TK gene (8, 17, 33) revealed two MluI sites, separated by 150 bp, on the two sides of the BglII site. Therefore, to obtain the size of vaccinia inserts, plasmids were digested with MluI and analyzed by agarose gel electrophoresis along with similarly digested pAGO (data not shown). All analyzed samples showed only two DNA bands, the smaller bands in digested pTs being always larger than the 150-bp band of pAGO. In addition to confirming the presence of inserts in the 10 recombinant viruses, these results indicated the absence of MluI sites in the inserts or in the rest of vaccinia sequences present in pTs (Fig. 2) . By subtracting 150 bp from the size of small MluI fragments, the size of DNA inserts in the 10 VpTs was determined (Table  3) . Upon further restriction analysis, DNA inserts in VpT61 and -63 proved to be identical (data not shown). Therefore, of eight VpT recombinant viruses originating from a single transfection with the Sau3A pool ( (8, 17, 33) . To sequence the portion of inserts adjacent to the 5' end of the HSV-TK gene, the HincII-MluI fragment containing the insert was isolated from pT plasmids after digestion with these two endonucleases, and the first position of its recessed 3' end was labeled with [ot-32P]dCTP, using the Klenow fragment of DNA polymerase. The end-labeled fragments obtained from nine different pT plasmids were then subjected to partial chemical modifications and cleavages for sequence determination (16) .
The GATC at the end of sequences (Fig. 7) is the Sau3A site ligated to the HSV sequence (not shown, although verified in all cases) such that the initiator ATG of HSV-TK would start 54 bp downstream of the last C. The presence of a GATC junction sequence in the nine VpT recombinant viruses shows the fidelity of in vitro and in vivo constructions. With inserts of VpT56 and -64 the BglII site is regenerated at the junction. The insert in VpT56 contains another GATC at nucleotide 40 (Fig. 7) . Since 10   20  30  40  50  60  70  80  90  15 TTTTGTGAGA TAGTCI.TGGC GACTAAATCA GATTATGAGG ATGCTGTTTT TTACTTTGTG GATGATGATA AA,^.TATGTAG TCGCGACTCC ATCATCGATC  20 GAACTTGTTA AAGAAGTCCA TTTAAGGCTT TAAAATTGAA TTGCGATTAT AAGATTAATG GCAGACACAG ACGATATTAT CGACTATGAA TCCGATGATC   22a ATTGAAAATA TTAAATTGAT AGCTGAAACA AATAGT6TAA AACTTTTA4A TAGCATTTCA AATGATCACC CATCTATTTA TGGTTTAACG TAAACGGATC  35 GCTAAAAAAA TATTTGAGAG AGATTGGGTA TCTAGCCACA GTAAATCGTT AAAAATTTAA AAAATAGAAA ATAGAAACGT ATAGAACGCC ATCATGGATC  38 CCATGACTAT CTCACAAAAG ACAGTATCCG TCTCCTTCCT CTATATTGAT TTAATTGTAT GTTTTTACAA TTATCAATAA AACATAAAAA TAATATGATC  56 AATTTCACTA GTTCGTTCTA CAATTACGTA ATGAAAATAG ATCTGTATTC TGTAGCGAAC TACCTGATTT TGCATGTAGT GGGTCAAAGA AAATCAGATC  60 GGAAAGTTCA AAAAGTCAGA CGGTAGTTAT CGAACACATC CTCACTATTC ATGGATGCAG AATATTTCTA TTCCTAGGAG TGTTGGATTT TATCCGGATC  63 GTTGCTGTCG We inserted randomly cleaved vaccinia genonlic fragments upstream of a foreign gene, then recombined the constructs in vivo into the viral genome, and finally examined the resulting recombinant viruses for the expression of the inserted chimeric gene. HSV-TK was chosen as the foreign gene for two reasons: its expression product could be assayed specifically by the phosphorylation of IdC, and viral recombinants expressing it could be selected in methotrexate-containing medium. However, selection of these recombinants required a TK-infecting virus. Rather than using a TK-mutant virus we chose to construct a TKrecombinant virus by inserting the entire pBR322 sequence in the body of the vaccinia TK gene. In fact, two recombinant viruses, VpB2 and VpB3, that differed by the orientation of pBR322 insertion were constructed. One advantage of using these recombinants is that insertion of a foreign gene cloned in plasmid pBR322 would take place by recombination within infected cells between homologous pBR322 sequences in plasmid and virus DNA. In this case, recombinant viruses containing the foreign gene flanked by pBR322 sequences would be identified and isolated by plaque hybridization (32) . In our specific strategy, however, the desired recombinant viruses expressed the HSV-TK gene and were selected in methotrexate-containing medium. We chose VpB3 rather than VpB2 in our experiments because we believed the expression of the chimeric HSV-TK gene in recombinant viruses would be less influenced by the cis-acting transcriptional regulatory sequences present upstream of the vaccinia TK gene which were located downstream and opposite in orientation to the HSV-TK gene. Similar sequences presumably present upstream of another nearby early gene (1) were placed upstream but still opposite in orientation to the HSV-TK gene.
Another advantage of using VpB2 or VpB3 as the infecting virus for insertion of foreign DNA is that the flanking of this DNA with pBR322 sequences in the constructed recombinant viruses provides a convenient means for the recovery of inserted DNA as part of a plasmid for growing in bacteria. This technique, applied here for the first time to the vaccinia genome, greatly simplified the characterization and sequencing of vaccinia DNA inserts. In cases where the sequence or the restriction map of foreign DNA is known, plasmid rescue may be used to verify the site-specific insertion of foreign DNA in a manner similar to the one we used for characterization of VpB2 and VpB3 viruses themselves.
That no TK+ recombinants were obtained upon transfection of VpB3-infected cells with pAGO confirms similar previous findings (13) suggesting that an endogenous promoter present upstream of the HSV-TK gene is not recognized by vaccinia transcriptional components. The formation of TK+ recombinant viruses upon transfection with constructed plasmid pools confirms that upstream insertion of some vaccinia sequences leads to expression of a foreign gene. Demonstration of nine different vaccinia DNA sequences upstream of the HSV-TK gene in TK+ viruses demonstrates clearly that our strategy enabled us to isolate several different genomic fragments promoting the expression of HSV-TK. It may thus be possible to isolate many more cis-acting regulatory signals from vaccinia DNA. If we assume that upstream regions of vaccinia genes are present among our inserts, they would presumably correspond to early genes since a recombinant virus expressing HSV-TK only at late times could not have grown in our selective medium added immediately after transfection.
Besides the fact that our inserts promote the expression of a foreign gene, other observations indicate that the upstream regions of some vaccinia genes may be included in our inserts. One observation was that a relatively low number of inserts promoted HSV-TK expression. An experiment in which individual plasmids of the Sau3A pool were used separately to transfect VpB3-infected ID cells showed that only 1 of 13 plasmids with inserts ranging from ca. 80 bp to 2.0 kb produced recombinant viruses that expressed HSV-TK (data not shown). It was in anticipation of these results that, in transfection experiments, we used either plasmid pools rather than individual plasmids or a first transfection step to obtain plasmids enriched in inserts with a cis-acting regulatory activity. Two other observations were based on analyzing the sequences shown in Fig. 7 . First, these sequences contain regions measuring 15 to 35 nucleotides with adenine-thymine (AT) contents higher than 90%. The only exception is the sequence from VpT56 which probably contains a similar region on the extreme left of the shown sequence because its nucleotide 1 is preceded by AAAA (data not shown). Runs of sequences containing only A and T residues measuring between 9 and 18 nucleotides are also present in these sequences. The sequence from VpT35 contains 24 A or T and only 1 G in the 25 residues between nucleotides 49 and 73. In VpT38 sequence, the 35 nucleotides preceding the GATC terminus contain 32 A or T residues. Highly AT-rich regions have been previously observed upstream of four early vaccinia genes (30, 31, 34 Depending on the position of the transcriptional start site, which may be located outside of the sequences shown in Fig.  7 , it is possible that some VpTs express HSV-TK as a fusion protein. For example, the ATG at nucleotide 94 in the sequence from VpT35 would correspond in mRNA to an AUG initiation codon that has a preferred sequence context (12) , is in phase with the HSV-TK reading frame, and is preceded (starting at 21 bases upstream) by the AT-rich region mentioned above. The relatively low level of TK activity observed in extracts from VpT-infected 1D cells (data not shown) is likely to result from the presence in mRNAs of upstream AUGs followed by translational stop codons, or from the synthesis of a fusion HSV-TK enzyme with a lower activity.
Studies on the identification of transcriptional start sites on these inserts and their mapping on the viral genome are currently in progress. Such studies should also help to evaluate the relative strength of these inserts in promoting the transcription of a downstream gene. After obtaining these results, some inserts might be exploitable in expressing other foreign genes. These genes would be ligated in vitro between the transcriptional start site and any restriction endonuclease site of the HSV-TK gene in a pT plasmid. Subsequent in vivo recombination of the construct into the corresponding VpT should generate conveniently selectable TK-recombinant viruses expressing the newly recombined gene.
